219 related articles for article (PubMed ID: 21138869)
1. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles.
Glazer ES; Zhu C; Massey KL; Thompson CS; Kaluarachchi WD; Hamir AN; Curley SA
Clin Cancer Res; 2010 Dec; 16(23):5712-21. PubMed ID: 21138869
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles.
Curley SA; Cherukuri P; Briggs K; Patra CR; Upton M; Dolson E; Mukherjee P
J Exp Ther Oncol; 2008; 7(4):313-26. PubMed ID: 19227011
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles.
Glazer ES; Massey KL; Zhu C; Curley SA
Surgery; 2010 Aug; 148(2):319-24. PubMed ID: 20541785
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles.
Glazer ES; Curley SA
Cancer; 2010 Jul; 116(13):3285-93. PubMed ID: 20564640
[TBL] [Abstract][Full Text] [Related]
5. Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells.
Cherukuri P; Curley SA
Methods Mol Biol; 2010; 624():359-73. PubMed ID: 20217608
[TBL] [Abstract][Full Text] [Related]
6. Autophagy and enhanced chemosensitivity in experimental pancreatic cancers induced by noninvasive radiofrequency field treatment.
Koshkina NV; Briggs K; Palalon F; Curley SA
Cancer; 2014 Feb; 120(4):480-91. PubMed ID: 24496866
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
Patra CR; Bhattacharya R; Wang E; Katarya A; Lau JS; Dutta S; Muders M; Wang S; Buhrow SA; Safgren SL; Yaszemski MJ; Reid JM; Ames MM; Mukherjee P; Mukhopadhyay D
Cancer Res; 2008 Mar; 68(6):1970-8. PubMed ID: 18339879
[TBL] [Abstract][Full Text] [Related]
8. Luciferase-based protein denaturation assay for quantification of radiofrequency field-induced targeted hyperthermia: developing an intracellular thermometer.
Raoof M; Zhu C; Kaluarachchi WD; Curley SA
Int J Hyperthermia; 2012; 28(3):202-9. PubMed ID: 22515341
[TBL] [Abstract][Full Text] [Related]
9. Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.
Raoof M; Corr SJ; Zhu C; Cisneros BT; Kaluarachchi WD; Phounsavath S; Wilson LJ; Curley SA
Nanomedicine; 2014 Aug; 10(6):1121-30. PubMed ID: 24650884
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles.
Qian Y; Qiu M; Wu Q; Tian Y; Zhang Y; Gu N; Li S; Xu L; Yin R
Sci Rep; 2014 Dec; 4():7490. PubMed ID: 25502402
[TBL] [Abstract][Full Text] [Related]
11. Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice.
Karmani L; Labar D; Valembois V; Bouchat V; Nagaswaran PG; Bol A; Gillart J; Levêque P; Bouzin C; Bonifazi D; Michiels C; Feron O; Grégoire V; Lucas S; Vander Borght T; Gallez B
Contrast Media Mol Imaging; 2013; 8(5):402-8. PubMed ID: 23740810
[TBL] [Abstract][Full Text] [Related]
12. Combination of active targeting, enzyme-triggered release and fluorescent dye into gold nanoclusters for endomicroscopy-guided photothermal/photodynamic therapy to pancreatic ductal adenocarcinoma.
Li H; Wang P; Deng Y; Zeng M; Tang Y; Zhu WH; Cheng Y
Biomaterials; 2017 Sep; 139():30-38. PubMed ID: 28582716
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab delivery and antitumor effects are enhanced by mild hyperthermia in a xenograft mouse model of pancreatic cancer.
Miyamoto R; Oda T; Hashimoto S; Kurokawa T; Inagaki Y; Shimomura O; Ohara Y; Yamada K; Akashi Y; Enomoto T; Kishimoto M; Yanagihara H; Kita E; Ohkohchi N
Cancer Sci; 2016 Apr; 107(4):514-20. PubMed ID: 26782353
[TBL] [Abstract][Full Text] [Related]
14. Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequency-based cancer therapy.
Raoof M; Corr SJ; Kaluarachchi WD; Massey KL; Briggs K; Zhu C; Cheney MA; Wilson LJ; Curley SA
Nanomedicine; 2012 Oct; 8(7):1096-105. PubMed ID: 22349096
[TBL] [Abstract][Full Text] [Related]
15. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.
Khan JA; Kudgus RA; Szabolcs A; Dutta S; Wang E; Cao S; Curran GL; Shah V; Curley S; Mukhopadhyay D; Robertson JD; Bhattacharya R; Mukherjee P
PLoS One; 2011; 6(6):e20347. PubMed ID: 21738572
[TBL] [Abstract][Full Text] [Related]
16. Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways.
Li L; Yue GG; Lau CB; Sun H; Fung KP; Leung PC; Han Q; Leung PS
Toxicol Appl Pharmacol; 2012 Jul; 262(1):80-90. PubMed ID: 22561874
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy.
Tonra JR; Deevi DS; Corcoran E; Li H; Wang S; Carrick FE; Hicklin DJ
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2197-207. PubMed ID: 16609035
[TBL] [Abstract][Full Text] [Related]
18. Selective radiofrequency ablation of tumor by magnetically targeting of multifunctional iron oxide-gold nanohybrid.
Beyk J; Tavakoli H
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2199-2209. PubMed ID: 31309302
[TBL] [Abstract][Full Text] [Related]
19. HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer.
Kubota T; Kuroda S; Kanaya N; Morihiro T; Aoyama K; Kakiuchi Y; Kikuchi S; Nishizaki M; Kagawa S; Tazawa H; Fujiwara T
Nanomedicine; 2018 Aug; 14(6):1919-1929. PubMed ID: 29885899
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effect Between Laser and Radiofrequency Heating of RGD-Gold Nanospheres on MCF7 Cell Viability.
Sánchez-Hernández L; Ferro-Flores G; Jiménez-Mancilla NP; Luna-Gutiérrez MA; Santos-Cuevas CL; Ocampo-García BE; Azorín-Vega E; Isaac-Olivé K
J Nanosci Nanotechnol; 2015 Dec; 15(12):9840-8. PubMed ID: 26682422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]